BPMC

Blueprint Medicines (BPMC)

Blueprint Medicines Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BPMC

<< 前へ 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2021/01/06	06 : 01	PR Newswire (US)	Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/29	06 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/23	06 : 15	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/19	06 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/18	06 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/17	22 : 00	PR Newswire (US)	Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT™ (avapritinib) for the Treatment of Advanc...	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/17	06 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/17	06 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/17	06 : 03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/07	22 : 00	PR Newswire (US)	Blueprint Medicines Data Presented at 62nd ASH Annual Meeting and Exposition Highlight Broad Commitment to Advance Patient Ca...	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/05	06 : 01	PR Newswire (US)	Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/04	06 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/02	06 : 12	Dow Jones News	Blueprint Medicines Says FDA Approves Gavreto to Treat Thyroid Cancer	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/12/02	05 : 15	PR Newswire (US)	Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Patients with Advanced or Metasta...	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/11/23	22 : 00	PR Newswire (US)	Blueprint Medicines To Present Broad Range of Data Reinforcing Commitment to Advance Patient Care in Systemic Mastocytosis at...	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/11/19	06 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/11/06	07 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/11/05	07 : 19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/11/04	06 : 01	PR Newswire (US)	Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/10/30	05 : 20	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/10/29	21 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/10/29	20 : 00	PR Newswire (US)	Blueprint Medicines Reports Third Quarter 2020 Financial Results	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/10/28	05 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/10/22	21 : 00	PR Newswire (US)	Blueprint Medicines to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/10/22	05 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/10/21	05 : 09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/10/10	05 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/10/10	05 : 06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/10/10	05 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation
2020/10/09	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BPMC	Blueprint Medicines Corporation